Palisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models [Yahoo! Finance]
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Palisade Bio Appoints Margery Fischbein to its Board of Directors [Yahoo! Finance]